Virios therapeutics to report first quarter 2021 financial results and provide corporate update on thursday, may 13, 2021

Atlanta--(business wire)--virios therapeutics, inc. (nasdaq: viri), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, announced today that its first quarter 2021 financial results will be reported on thursday, may 13, 2021 before the open of the financial markets. management will also host a webcast and conference call on may 13, 2021 at 8:30 a.m. et to discuss the results and
VIRI Ratings Summary
VIRI Quant Ranking